• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者血糖控制不佳的预测因素:药物依从性和体重指数在血糖与年龄关系中的作用。

Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age.

机构信息

Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

出版信息

Diabetes Res Clin Pract. 2012 May;96(2):119-28. doi: 10.1016/j.diabres.2011.12.003. Epub 2012 Jan 17.

DOI:10.1016/j.diabres.2011.12.003
PMID:22261095
Abstract

AIMS

To analyse predictors of glycaemic control including medication adherence and body mass index (BMI) in UK general practice patients with sub-optimally controlled type 2 diabetes.

METHODS

Baseline demographic, health- and treatment-related measures were evaluated as predictors of one year glycaemic control defined separately as HbA(1c)≤ 7.5% and a continuous measure of HbA(1c) concentration, using multivariate regression models. Significant predictors were adjusted for objectively assessed medication adherence and BMI.

RESULTS

One-year HbA(1c) concentration was associated with baseline HbA(1c) (p<0.001), BMI (p=0.02), and inversely associated with age (p=0.007) and objectively assessed adherence. Adherent patients had one-year (adjusted) HbA(1c) concentration 0.65% (95% CI -1.04, -0.25; p=0.001) lower than nonadherent. Odds ratios (95% CI) of HbA(1c)≤ 7.5% for 10-year higher age were 1.63 (1.08, 2.45); for adherent compared to non-adherent patients 1.89 (0.84, 4.25); for patients receiving >5 compared to ≤ 5 medications 0.32 (0.13, 0.76); and for each 1% increment in baseline HbA(1c) 0.48 (0.31, 0.73).

CONCLUSIONS

The lower HbA(1c) achieved from greater adherence to glucose lowering treatment is comparable to that achieved with additional medication. Relationships between older age and better glycaemic control are not explained by better adherence, but may partly relate to lower BMI.

摘要

目的

分析英国普通实践中血糖控制不佳的 2 型糖尿病患者的血糖控制预测因素,包括药物依从性和体重指数(BMI)。

方法

使用多元回归模型,评估基线人口统计学、健康和治疗相关措施,将其作为一年血糖控制的预测因素,分别定义为 HbA1c≤7.5%和 HbA1c 浓度的连续测量值。使用客观评估的药物依从性和 BMI 调整显著预测因素。

结果

一年的 HbA1c 浓度与基线 HbA1c(p<0.001)、BMI(p=0.02)相关,与年龄(p=0.007)和客观评估的依从性呈负相关。依从性好的患者一年的(调整后)HbA1c 浓度比不依从的患者低 0.65%(95%CI-1.04,-0.25;p=0.001)。年龄每增加 10 年,HbA1c≤7.5%的比值比(95%CI)为 1.63(1.08,2.45);与不依从的患者相比,依从的患者为 1.89(0.84,4.25);与服用>5 种药物相比,服用≤5 种药物的患者为 0.32(0.13,0.76);与基线 HbA1c 每增加 1%,为 0.48(0.31,0.73)。

结论

与增加药物治疗相比,更大程度地依从降血糖治疗可实现更低的 HbA1c。年龄较大与更好的血糖控制之间的关系不能用更好的依从性来解释,但可能部分与较低的 BMI 有关。

相似文献

1
Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age.2 型糖尿病患者血糖控制不佳的预测因素:药物依从性和体重指数在血糖与年龄关系中的作用。
Diabetes Res Clin Pract. 2012 May;96(2):119-28. doi: 10.1016/j.diabres.2011.12.003. Epub 2012 Jan 17.
2
Longitudinal association between medication adherence and glycaemic control in Type 2 diabetes.2 型糖尿病患者药物治疗依从性与血糖控制的纵向关联。
Diabet Med. 2013 Mar;30(3):338-44. doi: 10.1111/dme.12046.
3
The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.胰岛素治疗的 2 型糖尿病患者自我监测血糖值与糖化血红蛋白的关系。
Diabet Med. 2010 May;27(5):589-92. doi: 10.1111/j.1464-5491.2010.02955.x.
4
Measurements of medication adherence in diabetic patients with poorly controlled HbA(1c).测量 HbA(1c)控制不佳的糖尿病患者的药物依从性。
Diabet Med. 2010 Feb;27(2):210-6. doi: 10.1111/j.1464-5491.2009.02898.x.
5
The association between diabetes metabolic control and drug adherence in an indigent population.贫困人群中糖尿病代谢控制与药物依从性之间的关联。
Diabetes Care. 2002 Jun;25(6):1015-21. doi: 10.2337/diacare.25.6.1015.
6
Validity of medication adherence self-reports in adults with type 2 diabetes.成人 2 型糖尿病患者药物依从性自我报告的有效性。
Diabetes Care. 2013 Apr;36(4):831-7. doi: 10.2337/dc12-0410. Epub 2012 Nov 30.
7
Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.基层医疗中2型糖尿病患者血糖控制的不平等现象。
Diabet Med. 2005 Oct;22(10):1364-71. doi: 10.1111/j.1464-5491.2005.01662.x.
8
Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.1 型糖尿病患者起始持续皮下胰岛素输注治疗的血糖控制预测因素。
Diabet Med. 2010 Mar;27(3):339-47. doi: 10.1111/j.1464-5491.2009.02925.x.
9
A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.一项针对接受常规胰岛素治疗的 2 型糖尿病患者进行自我血糖监测的随机对照试验。
Diabetologia. 2014 May;57(5):868-77. doi: 10.1007/s00125-014-3168-1. Epub 2014 Jan 21.
10
Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.患者导向的滴定以实现使用每日一次基础胰岛素类似物的血糖目标:两种不同空腹血糖目标的评估 - TITRATE 研究。
Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.

引用本文的文献

1
Comparison of adherence between fixed and unfixed topical combination glaucoma therapies using Japanese healthcare/pharmacy claims database: a retrospective non-interventional cohort study.使用日本医疗保健/药房索赔数据库比较固定和非固定局部联合青光眼治疗的依从性:回顾性非干预性队列研究。
BMC Ophthalmol. 2021 Jan 21;21(1):52. doi: 10.1186/s12886-021-01813-w.
2
A statistical model to identify determinants of glycemic control in patients with type 2 diabetes with different pharmacotherapeutic profiles.一种用于识别具有不同药物治疗特征的 2 型糖尿病患者血糖控制决定因素的统计模型。
PLoS One. 2020 Jul 6;15(7):e0235376. doi: 10.1371/journal.pone.0235376. eCollection 2020.
3
The relationship between patients' perception of type 2 diabetes and medication adherence: a cross-sectional study in Japan.
2型糖尿病患者认知与用药依从性之间的关系:日本的一项横断面研究。
J Pharm Health Care Sci. 2019 Jan 22;5:2. doi: 10.1186/s40780-019-0132-8. eCollection 2019.
4
Adherence to oral glucose lowering drugs, quality of life, treatment satisfaction and illness perception: A cross-sectional study in patients with type 2 diabetes.口服降糖药物依从性、生活质量、治疗满意度及疾病认知:一项2型糖尿病患者的横断面研究
Saudi Pharm J. 2019 Jan;27(1):126-132. doi: 10.1016/j.jsps.2018.09.005. Epub 2018 Sep 7.
5
Psychosocial and Behavioral Correlates of A1C and Quality of Life Among Young Adults With Diabetes.青少年糖尿病患者 A1C 与生活质量的心理社会和行为相关因素。
Diabetes Educ. 2018 Dec;44(6):489-500. doi: 10.1177/0145721718804170. Epub 2018 Oct 8.
6
Utilization Patterns of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in Italy: A Retrospective Cohort Study.意大利2型糖尿病患者胰高血糖素样肽-1受体激动剂的使用模式:一项回顾性队列研究
Diabetes Ther. 2018 Apr;9(2):789-801. doi: 10.1007/s13300-018-0396-2. Epub 2018 Mar 10.
7
Trends in the management levels of metabolic risk factors in middle-aged and elderly patients with type 2 diabetes mellitus: The Korean National Health and Nutrition Examination Survey 1998-2014.1998 - 2014年韩国国民健康与营养检查调查:2型糖尿病中老年患者代谢危险因素管理水平的趋势
PLoS One. 2017 Dec 11;12(12):e0189361. doi: 10.1371/journal.pone.0189361. eCollection 2017.
8
Cross-sectional study of patients with type 2 diabetes in OR Tambo district, South Africa.南非奥·坦博区2型糖尿病患者的横断面研究。
BMJ Open. 2016 Jul 29;6(7):e010875. doi: 10.1136/bmjopen-2015-010875.
9
VITAMIN B12 LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ON METFORMIN.服用二甲双胍的2型糖尿病患者的维生素B12水平
Ann Ib Postgrad Med. 2015 Dec;13(2):79-83.
10
Diabetic patients' perspectives on the challenges of glycaemic control.糖尿病患者对血糖控制挑战的看法。
Afr J Prim Health Care Fam Med. 2015 Jul 30;7(1):767. doi: 10.4102/phcfm.v7i1.767.